Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

Clinical trial NCT05987696 · COMPLETED

Trial details

NCT number: NCT05987696
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

AML, Adult Minimal Residual Disease

Start date: 2023-07-31
Primary completion: 2025-01-17
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.